Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. February 1, 2007
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder November 11, 2006
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance July 7, 2006
Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors October 1, 2005
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebocontrolled dose-effect study November 13, 2003
Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia February 1, 2003
Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness January 1, 1999
